AzTrials
AzTrials

Osteoarthritis, KneeTKA4UNCT06955481

Study to Evaluate the Performance of Navigated TKA With OrthoPilot® pheno4u TKA Level 1

An observational study of Osteoarthritis, Knee and Joint Diseases, run by Aesculap AG at 4 sites in 2 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this PMCF study is to demonstrate the accuracy of navigation using the new pheno4uTKA Level 1 software for OrthoPilot Elite® and to evaluate its safety and performance. Patient-related outcome measures (PROM) will be acquired to investigate functional outcome and patient satisfaction. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Navigated Total Knee Arthroplasty
Type of treatment
Surgery or procedure
How many people
120 participants
Where
4 sitesin 2 countries
Study dates
7 Oct 2025to Jun 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients between 18 and 80 years of age having indication for a fixed-bearing total knee endoprosthesis, without retropatellar arthrosis requiring patella resurfacing

Who may be able to join

  • Indication for a TKA with the OrthoPilot® Navigation System with a Aesculap total knee endo-prosthesis
  • Written signed informed consent of patient
  • Willingness and mental ability to participate at the long-term follow-up examinations

Who cannot join

  • Pregnancy
  • Patients < 18 years or > 80 years
  • Patients unable to participate at the follow-up examination (physically, mentally)
  • Previous joint replacement at the index knee
  • ASA classification > 3 ( ASA I: A healthy patient without systemic diseases. ASA II: A patient with a mild systemic disease that is well controlled (e.g., well-controlled diabetes or hypertension). ASA III: A patient with a severe systemic disease that causes functional limitations (e.g., poorly controlled diabetes, COPD). ASA IV: A patient with a life-threatening systemic disease (e.g., severe heart failure, sepsis). ASA V: A dying patient who is not expected to survive without the operation. ASA VI: A deceased patient whose organs are being removed for donation.)

Trial locations and contacts

4 sites in 2 countries. Contact the study team or a site near you to ask about taking part.

4 sites in 2 countries

Germany3 sites, 3 recruiting
  • Park-Klinik Weißensee

    Berlin, 13086

    Oliver Hauschild, Prof.Dr.med, +49 7531 801 ext. 0

    Oliver Hauschild, Prof. Dr.

    Recruiting
  • Universitätsklinikum Carl Gustav Carus

    Dresden, 01307

    Jörg Lützner, Prof. Dr., +49 351 458 150 ext. 0

    Jörg Lützner, Prof. Dr.

    Not yet recruiting
  • Klinikum Konstanz GmbH

    Konstanz, Baden-Wurttemberg, 78464

    Gunnar Ochs, Prof.Dr.med, +49 7531 801 ext. 0

    Gunnar Ochs, Prof. Dr.

    Not yet recruiting

Other trials in Germany

Czechia1 site, 1 recruiting
  • Šumperk Hospital Inc.

    Šumperk, 78701

    Ján Debre, Dr.med

    +420 583 333 ext. 0

    Not yet recruiting

Other trials in Czechia

About this study

Official title: Prospective, Single-arm, Multicenter Study to Evaluate the Performance of Navigated Total Knee Arthroplasty Using the OrthoPilot and the Software pheno4u TKA Level 1

The purpose of this PMCF study is to demonstrate the accuracy of navigation using the new pheno4uTKA Level 1 software for OrthoPilot Elite® and to evaluate its safety and performance.

Patient-related outcome measures (PROM) will be acquired to investigate functional outcome and patient satisfaction.

Being tested
Navigated Total Knee Arthroplasty
Keywords
Navigation, Total Knee Arthroplasty, OrthoPilot
Medical subject headings
Osteoarthritis, Knee, Joint Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Navigated Total Knee ArthroplastyProcedure or surgery

    The OrthoPilot® Software Pheno4u TKA Level 1 is an application software for computer aided navigation of surgical instruments and serves (in combination with compatible hardware and compatible navigated instruments) as an optional aid for the surgeon during the preparation of the implant site for a compatible knee endoprosthesis.

Study groups in NCT06955481
Study groupRoleWhat they receive
pheno4u TKA Level 1Navigation of TKA (Total Knee Arthroplasty) using the new pheno4uTKA Level 1 software for OrthoPilot Elite®.
Receives: Procedure: Navigated Total Knee Arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of the surgical accuracy between the new OrthoPilot Software and the previous OrthoPilot Software

    The primary variable delta (aHKA), is defined as the difference in the arithmetic hip-knee-angle (aHKA) between the 3 months postoperative and the intraoperatively planned value. The aHKA is calculated as the difference of the mechanical medial proximal tibial angle (MPTA) and the mechanical lateral distal femoral angle (LDFA), both measured in degrees.

    Measured: 3 months post OP

Secondary outcomes (8)
  1. Implant survival

    Secondary interventions at the index knee

    Measured: ongoing, up to 2 years follow-up

  2. Oxford Knee Score (OKS)

    The Oxford Knee Score (OKS) is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome.

    Measured: Preoperative,3 months-, 12 months and 2 years post operative

  3. Forgotten Joint Score (FJS)

    The FJS-12 contains 12 questions. Every question is scored 1 (never) to 5 (mostly) according to the selected response categories. Thus, the raw score ranges from 12 to 60. The raw score is linearly transformed to a 0-100 scale and then reversed to obtain the final score.

    Final score = 100 - ((sum(item01 to item12) - 12)/48*100). Lower scores indicate less awareness of the operated knee during daily activities. The range of the final score is from 0 to 100 (where 0 is worst and 100 means best score)

    Measured: Preoperative,3 months-, 12 months and 2 years post operative

  4. Quality of Life (EQ-5D-5L)

    Quality of life of the patients will be analyzed using the 5-dimensions 5-level measure of the EuroQol Group (EQ-5D-5L), which is a simple and generic measure for clinical and economic assessment.

    The questionnaire covers five different dimensions (mobility, self-care, usual activities,pain/discomfort, anxiety/depression) rated in 5 levels (from "the worst health you can imagine" to "the best health you can imagine"). The questionnaire is filled by the patients themselves.

    Measured: Preoperative, Postoperative 3 Months + /- 6 weeks, Postoperative 12 months + /- 6 weeks, Postoperative 2 year + /- 3 months

  5. NET Promotor Score (NPS)

    The Net Promoter Score (NPS) was developed for measuring satisfaction in economic research.

    Colloquially, it is referred to as the "friends and family test". In the healthcare sector, the NPS is used as an overarching measure of patient satisfaction. The NPS metric evaluates the likelihood that a patient will recommend the received healthcare service to others. The NPS is assessed using a scale from 1 to 10. A rating between 9 and 10 is classified as a promoter. A rating between 7 and 8 is considered neutral, and a rating between 0 and 6 is deemed a detractor. The overall score is simply calculated by subtracting the percentage of detractors from the percentage of promoters.

    Scores range from -100 (everyone is a detractor) to +100 (everyone is a promoter). In the industry, a positive score is viewed favorably, and scores above 50 are considered indicative of strong performance.

    Measured: Postoperative 3 Months + /- 6 weeks, Postoperative 12 months + /- 6 weeks, Postoperative 2 year + /- 3 months

  6. Anterior knee pain

    Anterior knee pain will be used to evaluate the performance of the implantation and the implant itself.

    Rating Description Points:

    0 = No pain (0 Points) I = Mild pain that does not intrude on daily activities (5 Points) II= Moderate pain that is a nuisance; patient not considering further surgery (10 Points) III= Severe pain; patient considering further surgery (15 Points)

    Measured: Preoperative,3 months-, 12 months and 2 years post operative

  7. Radiological results

    Routinely performed radiographic images are used to evaluate the status of the affected knee, preoperatively, and the status of the implant components, postoperatively. Analysis of parameters will be defined in the radiographic protocol, where precise definition of the implant alignment parameter of the tibial and femoral component by measurement of the LDFA (laterale distale Femurankle) and MPTA (medial proximal Tibiaankle) is given. Both ankles have the same unit and are measured in degrees.

    Measured: Preoperative, Discharge, 1 year post op

  8. All (Serious) Adverse Events

    During the course of the study, any upcoming intra- or postoperative (serious) adverse will be documented. The total number of AEs will be summarized and further evaluated by the sponsor and reported according to local legislation and necessity. Recorded complications will be categorized and analyzed to assess the safety of the investigational product.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2025
  2. Study start7 Oct 2025
  3. Primary completionJul 2027 (estimated)
  4. Study completionJun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06955481
Sponsor's protocol ID
AAG-O-H-25084
Acronym
TKA4U
Status last verified
Nov 2025
First submitted
25 Apr 2025
Last updated
17 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoarthritis, Knee and Joint Diseases, run by Aesculap AG at 4 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Germany, Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Heike Oberascher (+49 7461 95 ext. 0, studies@aesculap.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of the surgical accuracy between the new OrthoPilot Software and the previous OrthoPilot Software (time frame: 3 months post OP). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2025; AzTrials last refreshed its copy on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in